STAT3 and melanoma: The hyperactivation of JAKs/STAT3 is closely linked to cancer immune tolerance (45), with elevated levels of phosphorylated STAT3 observed across various cancers, including breast (46, 47), lung (48), liver (49), GI (44, 50), prostate (51), fibrosarcoma (52), and melanoma (53).